Who We Are
CFA’s leadership team has a wide array of leadership experience in outbreak analytics, epidemiological analysis, risk communication, and much more. Meet our leaders below.
Marc Lipsitch, DPhil, serves as the director of science in CDC’s Center for Forecasting and Outbreak Analytics (CFA). Dr. Lipsitch received his BA from Yale University and DPhil from the University of Oxford. Dr. Lipsitch is seconded to CDC from the Harvard T.H. Chan School of Public Health, where he is professor of epidemiology and director of the Center for Communicable Disease Dynamics. He is an internationally recognized expert in infectious disease transmission modeling and has been a leading scientific authority in scientific research and public communication during the COVID-19 pandemic. His COVID-19 research has been in areas including the ethics of human challenge COVID-19 studies, transmission dynamics, basic epidemiology, clinical severity and sequelae, vaccine allocation, vaccine effectiveness, and equity. That work builds on his earlier research focus, which included antimicrobial resistance, epidemiologic methods, mathematical modeling of infectious disease transmission, bacterial and human population genetics and evolution, and molecular genetics of Streptococcus pneumoniae infection and immunity. He is an elected member of the American Academy of Microbiology and the National Academy of Medicine.
Dylan George, PhD, is the director of operations for the Center for Forecasting and Outbreak Analytics (CFA) at the U.S. Centers for Disease Control and Prevention. CFA is building world class data and analytics capabilities to guide interventions in public health emergencies and pandemics.
Before joining CDC, Dr. George was a vice president at Ginkgo Bioworks, where he helped develop improved real-time infectious disease monitoring capabilities and analytics for pandemic response. Before Ginkgo, Dr. George was a vice president at In-Q-Tel (IQT), where he vetted life science, healthcare deals, and developed science and technical strategy to strengthen capacity within the United States to counter biological threats from infectious disease.
Recently, Dr. George served on the Biden-Harris transition team working on national security policy for the COVID-19 response, and on the agency review team for the Department of Health and Human Services. Dr. George served Dr. John Holdren, assistant to the president for science and technology and director of the White House Office of Science and Technology Policy (OSTP), as senior policy advisor for biological threat defense. Among other responsibilities at OSTP, Dr. George provided technical expertise and interagency coordination supporting the response to the Ebola outbreak in West Africa. During 2013–2014, Dr. George worked in the Department of Health and Human Services within the Biomedical Advanced Research and Development Authority, where he led a team that developed analytical approaches to assess risks from emerging infectious diseases and other mass casualty events. During 2009–2013, Dr. George worked within the Department of Defense on anticipating and assessing infectious disease risks that would affect mission readiness and force health protection. Dr. George worked at the National Science Foundation within the divisions of Biological Infrastructure and Environmental Biology. While at the National Science Foundation, Dr. George also supported the National Ecological Observatory Network and the Ecology of Infectious Diseases program.
Dr. George received his PhD from Colorado State University and focused on quantitative analytical approaches for considering how clinically severe pathogens (e.g., Yersinia pestis, rabies) persist within wildlife populations.
Alison Kelly joins the Center for Forecasting and Outbreak Analytics from CDC’s Office of Financial Resources (OFR) where she has worked since February 2016, most recently as the director of the Office of Appropriations. In this capacity, she led the formulation of budgets for CDC’s annual and supplemental appropriations, including high-visibility projects such as the high containment continuity laboratory, responses to Ebola, E-cigarette and vaping related lung injuries (EVALI), and COVID-19. Before coming to OFR, she served as the associate director for policy in CDC’s Center for Global Health (CGH). She led a team that was instrumental in establishing CDC’s $600 million global health security program. Her previous leadership positions within CGH included serving as director of the Overseas Operations Office and acting principal deputy of the Division of Global HIV/AIDS. She also served overseas as business service officer and deputy director for the HIV/AIDS program in CDC’s office in Beijing, China. Before her assignment in China, she served as CDC’s strategy and innovation officer for the Coordinating Office for Global Health (COGH).
Ms. Kelly has been with CDC for 29 years and has held management and policy-related positions in the National Center on Birth Defects and Developmental Disabilities, National Center for Chronic Disease Prevention and Health Promotion, and the National Center for Environmental Health. She has also worked in CDC’s Washington Office.
Ms. Kelly received her master’s degree in international affairs and Pacific studies from the University of California, San Diego, in 1992, with a specialization in comparative public policy and an emphasis in program design and evaluation. She has a bachelor’s degree in psychology and Asian studies from Dartmouth College.
CFA is growing! We are in the process of recruiting a diverse and highly qualified team of scientists, data engineers, software developers, scientific and risk communicators, project managers, and much more. View our current opening posted on USAJobs.